Meridian Bioscience Announces Agreement to Acquire Business of GenePOC; Adds State-of-the-Art Molecular Diagnostics Platform
Go back to Meridian Bioscience Announces Agreement to Acquire Business of GenePOC; Adds State-of-the-Art Molecular Diagnostics Platform| Meridian Bioscience, Inc. (NASDAQ: VIVO) | Delayed: 5.60 -0.27 (4.6%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.87 | 52 Week High | $21.49 | |||
| Open | $5.52 | 52 Week Low | $15.75 | |||
| Day High | $6.04 | P/E | 6.36 | |||
| Day Low | $5.50 | EPS | $0.88 | |||
| Volume | 1,140,945 | |||||
